Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants

dc.contributor.author
Natera de Benito, Damiel
dc.contributor.author
Olival T., Jonathan F.
dc.contributor.author
Garcia Cabau, Carla
dc.contributor.author
Jou, Cristina
dc.contributor.author
Roldan, Mònica
dc.contributor.author
Codina, Anna
dc.contributor.author
Expósito Escudero, Jessica
dc.contributor.author
Batlle, Cristina
dc.contributor.author
Carrera García, Laura
dc.contributor.author
Ortez, Carlos Ignacio
dc.contributor.author
Salvatella i Giralt, Xavier
dc.contributor.author
Palau Martínez, Francesc
dc.contributor.author
Nascimento, Andrés
dc.contributor.author
Hoenicka, Janet
dc.date.issued
2023-07-04T10:58:47Z
dc.date.issued
2023-07-04T10:58:47Z
dc.date.issued
2023-01-18
dc.date.issued
2023-06-29T11:04:35Z
dc.identifier
2328-9503
dc.identifier
https://hdl.handle.net/2445/200262
dc.identifier
6573953
dc.identifier
36651622
dc.description.abstract
Mutations in ANXA11 cause amyotrophic lateral sclerosis (ALS) and have recently been identified as a cause of multisystem proteinopathy and adult-onset muscular dystrophy. These conditions are adult-onset diseases and result from the substitution of Aspartate 40 (Asp40) for an apolar residue in the intrinsically disordered domain (IDD) of ANXA11. Some ALS-related variants are known to affect ANXA11 IDD; however, the mechanism by which the myopathy occurs is unknown.Genetic analysis was performed using WES-trio. For the study of variant pathogenicity, we used recombinant proteins, muscle biopsy, and fibroblasts.Here we describe an individual with severe and rapidly progressive childhood-onset oculopharyngeal muscular dystrophy who carries a new ANXA11 variant at position Asp40 (p.Asp40Ile; c.118_119delGAinsAT). p.Asp40Ile is predicted to enhance the aggregation propensity of ANXA11 to a greater extent than other changes affecting this residue. In vitro studies using recombinant ANXA11p.Asp40Ile showed abnormal phase separation and confirmed this variant is more aggregation-prone than the ALS-associated variant ANXA11p.Asp40Gly . The study of the patient's fibroblasts revealed defects in stress granules dynamics and clearance, and muscle histopathology showed a myopathic pattern with ANXA11 protein aggregates. Super-resolution imaging showed aggregates expressed as pearl strips or large complex structures in the sarcoplasm, and as layered subsarcolemmal chains probably reflecting ANXA11 multifunctionality.We demonstrate common pathophysiology for disorders associated with ANXA11 Asp40 allelic variants. Clinical phenotypes may result from different deleterious impacts of variants upon ANXA11 stability against aggregation, and differential muscle or motor neuron dysfunction expressed as a temporal and tissue-specific continuum.© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
dc.format
18 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Wiley
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/acn3.51731
dc.relation
Annals Of Clinical And Translational Neurology, 2023, vol. 10, num. 3, p. 408-425
dc.relation
https://doi.org/10.1002/acn3.51731
dc.rights
cc by (c) Natera de Benito, Damiel et al, 2023
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
dc.subject
Esclerosi lateral amiotròfica
dc.subject
Neurones motores
dc.subject
Amyotrophic lateral sclerosis
dc.subject
Motor neurons
dc.title
Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Fitxers en aquest element

FitxersGrandàriaFormatVisualització

No hi ha fitxers associats a aquest element.

Aquest element apareix en la col·lecció o col·leccions següent(s)